- Home
- ZLAB vs NWBI Comparison
ZLAB vs NWBI Comparison
Compare ZLAB & NWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZLAB | NWBI |
|---|---|---|
| Founded | 2013 | 1896 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZLAB | NWBI |
|---|---|---|
| Price | $17.92 | $13.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $51.52 | $13.67 |
| AVG Volume (30 Days) | 795.4K | ★ 1.2M |
| Earning Date | 02-26-2026 | 01-26-2026 |
| Dividend Yield | N/A | ★ 6.00% |
| EPS Growth | N/A | ★ 16.74 |
| EPS | N/A | ★ 0.92 |
| Revenue | $441,629,000.00 | ★ $599,086,000.00 |
| Revenue This Year | $26.16 | N/A |
| Revenue Next Year | $30.62 | $4.77 |
| P/E Ratio | ★ N/A | $14.50 |
| Revenue Growth | ★ 24.14 | 20.28 |
| 52 Week Low | $15.96 | $10.75 |
| 52 Week High | $44.34 | $13.62 |
Technical Indicators
Market Signals| Indicator | ZLAB | NWBI |
|---|---|---|
| Relative Strength Index (RSI) | 45.10 | 64.05 |
| Support Level | $15.96 | $13.07 |
| Resistance Level | $17.86 | $13.59 |
| Average True Range (ATR) | 0.62 | 0.30 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 44.03 | 81.10 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.